Pages that link to "Item:Q5170208"
From MaRDI portal
The following pages link to Simple benchmark for complex dose finding studies (Q5170208):
Displaying 6 items.
- Patient-specific dose finding in seamless phase I/II clinical trials (Q5043686) (← links)
- A new design of the continual reassessment method (Q5082671) (← links)
- A continual reassessment method without undue risk of toxicity (Q6171847) (← links)
- Combined criteria for dose optimisation in early phase clinical trials (Q6625215) (← links)
- Seamless phase I/II design for novel anticancer agents with competing disease progression (Q6627954) (← links)
- Surv-CRM-12: a Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression (Q6629418) (← links)
